Raymond James Financial Services Advisors’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $221K | Buy |
+1,214
| New | +$180K | ﹤0.01% | 3133 |
|
|
2023
Q4 | – | Sell |
-11,189
| Closed | -$1.33M | – | 3361 |
|
|
2023
Q3 | $1.33M | Buy |
11,189
+3,533
| +46% | +$527K | ﹤0.01% | 1754 |
|
|
2023
Q2 | $1.36M | Sell |
7,656
-61
| -0.8% | -$11.2K | ﹤0.01% | 1752 |
|
|
2023
Q1 | $1.27M | Buy |
7,717
+2,319
| +43% | +$399K | ﹤0.01% | 1759 |
|
|
2022
Q4 | $850K | Sell |
5,398
-443
| -8% | -$67.4K | ﹤0.01% | 1944 |
|
|
2022
Q3 | $880K | Buy |
5,841
+2,690
| +85% | +$448K | ﹤0.01% | 1887 |
|
|
2022
Q2 | $518K | Sell |
3,151
-430
| -12% | -$82.8K | ﹤0.01% | 2252 |
|
|
2022
Q1 | $797K | Sell |
3,581
-386
| -10% | -$86.5K | ﹤0.01% | 2101 |
|
|
2021
Q4 | $942K | Buy |
3,967
+42
| +1% | +$9.81K | ﹤0.01% | 2008 |
|
|
2021
Q3 | $916K | Sell |
3,925
-190
| -5% | -$39.8K | ﹤0.01% | 2021 |
|
|
2021
Q2 | $847K | Sell |
4,115
-475
| -10% | -$97.7K | ﹤0.01% | 2055 |
|
|
2021
Q1 | $943K | Sell |
4,590
-1,582
| -26% | -$334K | ﹤0.01% | 1896 |
|
|
2020
Q4 | $1.32M | Sell |
6,172
-3,226
| -34% | -$626K | ﹤0.01% | 1536 |
|
|
2020
Q3 | $1.72M | Sell |
9,398
-5
| -0.1% | -$941 | ﹤0.01% | 1250 |
|
|
2020
Q2 | $1.73M | Sell |
9,403
-1,011
| -10% | -$201K | 0.01% | 1174 |
|
|
2020
Q1 | $2.1M | Sell |
10,414
-6,841
| -40% | -$1.32M | 0.01% | 870 |
|
|
2019
Q4 | $3.23M | Sell |
17,255
-49,774
| -74% | -$8.57M | 0.01% | 923 |
|
|
2019
Q3 | $10.7M | Sell |
67,029
-23,123
| -26% | -$4.6M | 0.04% | 449 |
|
|
2019
Q2 | $22.7M | Sell |
90,152
-5,326
| -6% | -$1.23M | 0.09% | 244 |
|
|
2019
Q1 | $22.9M | Buy |
95,478
+4,348
| +5% | +$1.04M | 0.09% | 237 |
|
|
2018
Q4 | $20.9M | Buy |
91,130
+4,844
| +6% | +$1.19M | 0.11% | 207 |
|
|
2018
Q3 | $24.4M | Buy |
86,286
+1,165
| +1% | +$341K | 0.11% | 203 |
|
|
2018
Q2 | $25M | Buy |
85,121
+23,300
| +38% | +$6.37M | 0.13% | 174 |
|
|
2018
Q1 | $15.6M | Buy |
61,821
+12,373
| +25% | +$2.91M | 0.09% | 258 |
|
|
2017
Q4 | $10.7M | Buy |
49,448
+37,445
| +312% | +$7.58M | 0.07% | 334 |
|
|
2017
Q3 | $2.23M | Buy |
12,003
+599
| +5% | +$104K | 0.01% | 870 |
|
|
2017
Q2 | $1.97M | Buy |
11,404
+2,574
| +29% | +$413K | 0.01% | 897 |
|
|
2017
Q1 | $1.35M | Sell |
8,830
-4,633
| -34% | -$677K | 0.01% | 1010 |
|
|
2016
Q4 | $1.98M | Sell |
13,463
-5,470
| -29% | -$792K | 0.02% | 786 |
|
|
2016
Q3 | $2.39M | Buy |
18,933
+3,997
| +27% | +$482K | 0.02% | 688 |
|
|
2016
Q2 | $1.68M | Sell |
14,936
-8,198
| -35% | -$851K | 0.02% | 819 |
|
|
2016
Q1 | $2.41M | Buy |
23,134
+11,829
| +105% | +$1.13M | 0.03% | 560 |
|
|
2015
Q4 | $1.27M | Buy |
+11,305
| New | +$1.25M | 0.01% | 817 |
|
Other funds holding ICUI
Raymond James Financial Services Advisors's ICUI Position: Q3 2024 in Review
Raymond James Financial Services Advisors opened a new position in ICU Medical (ICUI) in Q3 2024: 1,214 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3133 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in ICUI as recently as Q3 2023.
Raymond James Financial Services Advisors first reported a position in ICUI in Q4 2015 and has held it in 33 quarters since. The position peaked at $25M in Q2 2018. 289 funds tracked by Wall St. Rank hold ICUI as of Q3 2024.
- Raymond James Financial Services Advisors held 1,214 shares of ICU Medical worth $221K as of Q3 2024.
- ICU Medical was a new Raymond James Financial Services Advisors position in Q3 2024.
- ICU Medical made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3133 holding.
- Raymond James Financial Services Advisors first reported a position in ICU Medical in Q4 2015 and has held it in 33 quarters since.
- Raymond James Financial Services Advisors's ICU Medical position peaked at $25M in Q2 2018.
- 289 funds tracked by Wall St. Rank held ICU Medical as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.